SAMANTHA PARKER: Open Payments
NPI 1538784046 · IVOR, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 56 payments from 12 companies in 2025. Trend: 2023 $541 · 2024 $996 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $189 |
| Novo Nordisk Inc | 8 | $183 |
| Supernus Pharmaceuticals, Inc. | 4 | $160 |
| Corcept Therapeutics | 3 | $91 |
| ABBVIE INC. | 5 | $78 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Exact Sciences Corporation | 2 | $41 |
| Dexcom, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $38 |
Products named: CAPLYTA, Qelbree, FARXIGA, Wegovy, Korlym, VRAYLAR, Auvelity, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
